Publications

Publications by Børre Fevang

8 publications found

Publications 2010

1. Gregersen S, Aaløkken TM, Mynarek G, Fevang B, Holm AM, Ueland T, Aukrust P, Kongerud J, Johansen B, Frøland SS (2010)
   Development of pulmonary abnormalities in patients with common variable immunodeficiency: associations with clinical and immunologic factors
   Ann Allergy Asthma Immunol, 104 (6), 503-10
   PubMed 20568383

Publications 2009

1. Damås JK, Landrø L, Fevang B, Heggelund L, Frøland SS, Aukrust P (2009)
   Enhanced levels of the CCR7 ligands CCL19 and CCL21 in HIV infection: correlation with viral load, disease progression and response to highly active antiretroviral therapy
   AIDS, 23 (1), 135-8
   PubMed 19050397
2. Fevang B, Eugen-Olsen J, Yndestad A, Brosstad F, Beiske K, Aukrust P, Frøland SS (2009)
   Enhanced levels of urokinase plasminogen activator and its soluble receptor in common variable immunodeficiency
   Clin Immunol, 131 (3), 438-46
   PubMed 19232508
3. Fevang B, Yndestad A, Damås JK, Bjerkeli V, Ueland T, Holm AM, Beiske K, Aukrust P, Frøland SS (2009)
   Chemokines and common variable immunodeficiency; possible contribution of the fractalkine system (CX3CL1/CX3CR1) to chronic inflammation
   Clin Immunol, 130 (2), 151-61
   PubMed 18938112

Publications 2008

1. Dahl CP, Gullestad L, Fevang B, Holm AM, Landrø L, Vinge LE, Fiane AE, Sandberg WJ, Otterdal K, Frøland SS, Damås JK, Halvorsen B, Aukrust P, Øie E, Yndestad A (2008)
   Increased expression of LIGHT/TNFSF14 and its receptors in experimental and clinical heart failure
   Eur J Heart Fail, 10 (4), 352-9
   PubMed 18353719
2. Smith C, Halvorsen B, Otterdal K, Waehre T, Yndestad A, Fevang B, Sandberg WJ, Breland UM, Frøland SS, Oie E, Gullestad L, Damås JK, Aukrust P (2008)
   High levels and inflammatory effects of soluble CXC ligand 16 (CXCL16) in coronary artery disease: down-regulatory effects of statins
   Cardiovasc Res, 79 (1), 195-203
   PubMed 18339644

Publications 2007

1. Bjerkeli V, Damås JK, Fevang B, Holter JC, Aukrust P, Frøland SS (2007)
   Increased expression of fractalkine (CX3CL1) and its receptor, CX3CR1, in Wegener's granulomatosis--possible role in vascular inflammation
   Rheumatology (Oxford), 46 (9), 1422-7
   PubMed 17616549
2. Damås JK, Smith C, Øie E, Fevang B, Halvorsen B, Waehre T, Boullier A, Breland U, Yndestad A, Ovchinnikova O, Robertson AK, Sandberg WJ, Kjekshus J, Taskén K, Frøland SS, Gullestad L, Hansson GK, Quehenberger O, Aukrust P (2007)
   Enhanced expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental atherosclerosis: possible pathogenic role in plaque destabilization
   Arterioscler Thromb Vasc Biol, 27 (3), 614-20
   PubMed 17170367